Acadia Pharmaceuticals Overview
Valuation check: ACAD's PEG ratio is 72.33, above the Healthcare sector average of 2.89.
Get informed when a big investor buys or sells
+ Follow72.33
The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.
As of the most recent data, ACAD shows a PEG ratio of 72.33. That is above the Healthcare sector average of 2.89. Scroll down for historical charts and peer comparison views.
The Healthcare sector average PEG ratio is about 2.89. Acadia Pharmaceuticals is at 72.33, which is higher that average. That is roughly 2401.9% above the sector mean. Use the comparison chart on this page to see how ACAD stacks up against individual peers as well.
Investors watch ACAD's PEG ratio because it compresses price and fundamentals into one number that is easy to compare across companies and over time. Acadia Pharmaceuticals's latest reading is 72.33. Combining that with growth, ROE, and debt metrics usually beats relying on a single multiple.
Besides this peg ratio page, Stockcircle has Acadia Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect PEG ratio (currently 72.33) with ownership activity and broader fundamentals.
The Healthcare average PEG ratio is about 2.89, while ACAD is at 72.33. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.
